Peter Wolpert


Peter has a passionate interest for developing innovative ventures to globally successful companies within Life Science and Tech.

Peter joined Industrifonden in 2022 as CEO, after 25 years of business development as a CEO, founder, in board roles and as an advisor. He was CEO/Founder of Moberg Pharma which commercial operations in 2019 were acquired by US Private Equity firms Roundtable Healthcare and Signet Healthcare, after rapid organic and M&A-driven growth. Peter has contributed to the development of multiple companies in Healthcare and Tech, including A3P Biomedical, Appeal Software Solutions, Karolinska Development, MedUniverse, och OncoZenge. He worked in the US for a few years and started his professional career at Ericsson and McKinsey & Co.

Peter holds a M.Sc. in Engineering Physics from the Royal Institute of Technology and a M.Sc. in Finance and Business Adminstration from the Stockholm School of Economics.

By continuing on the site you accept our terms and conditions for cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.